The present data indicate that the prognosis for patients with recurrent breast cancer is mainly related to the N category.Vengono riportati i risultati a distanza di 120 donne mastectomizzate per cancro mammario fra il 1955 e il 1965 nelle quali la prima ricaduta era rappresentata da una ...
Cutaneous metastasis of inflammatory breast carcinoma mimicking an erythema annulare centrifugum: a sign of locally recurrent cancer. Clin Exp Dermatol. 2016;41(8):906–10. Article CAS PubMed Google Scholar Tabak GH, Akdogan N, Ates Ozdemir D. Cutaneous metastasis of breast carcinoma presenting...
The cohort included unifocal, unilateral, nonrecurrent, nonmetastatic tumours, excluding T4 tumours (inflammatory, chest wall or skin invasion). All patients included in the cohort received NAC. Patients were treated according to national guidelines. Approved by the Breast Cancer Study Group of ...
In the present study, we aimed to clarify the potential of oncogene amplifications as markers for the prediction of (i) (relapse-free) survival, (ii) response to first-line endocrine therapy and (iii) subsequent chemotherapy in patients with recurrent breast cancer. To attain this goal, amplif...
Malebreastcancer(MBC)patientsseemtohaveinferiorsurvivalcomparedtofemale(FBC)ones,whichisnotfullyexplainedbyusualprognosticfactors.Recurrenceanalysiscouldshowdifferencesinrelapsepatternsand/orinpatients’approachesthatjustifytheseoutcomes.RetrospectiveanalysisofMBCpatientstreatedinacancercenterbetween1990and2014,lookingfor...
The patients in the series were followed for up to 50 months during which time 84 patients have developed recurrent disease. Life table analyses of the results showed that the probability of remaining free from recurrence was greater in women whose carcinomas had low activities of 6-...
Changes of cytokines and thyroid function in patients with recurrent breast cancer. The state or nonthyroidal illness is often observed in patients with . High levels of cytokines are frequently observed in patients. Recent studies have sh... T Yokoe,Y Iino,H Takei,... - 《Anticancer Researc...
Clin Cancer Res. 2019;25(8):2450-2457. doi:10.1158/1078-0432.CCR-18-3121PubMedGoogle ScholarCrossref 11. Biomarker trial of apalutamide and radiation for recurrent prostate cancer. ClinicalTrials.gov identifier NCT03371719. Updated March 2, 2021. Accessed August 17, 2021. https://...
Wu et al. [52] conducted a matched retrospective analysis of 57 patients with recurrent TC and found that obesity was an independent risk factor for recurrence. Patients with normal weights had higher disease-free survival rates than those with underweight, overweight, or obesity. However, in the...
Recurrent cancer after breast-conserving surgery with radiation therapy for ductal carcinoma in situ: mammographic features, method of detection, and stage... The purpose of our study was to determine the mammographic appearance, detection method, and stage of ipsilateral breast tumor recurrence in wom...